https://www.gosh.nhs.uk/news/statement-regarding-recent-social-media-posts/
Statement regarding recent social media posts
5 Apr 2024, 3:51 p.m.
This statement is made in response to allegations made across social media in relation to antisemitism awareness training being planned by the Trust.
A spokesperson for Great Ormond Street Hospital said: “Great Ormond Street Hospital does not tolerate discrimination of any kind, including antisemitism. Respect for all our patients, families and colleagues, is at the heart of our ethos. We strive for GOSH to be a welcoming, inclusive and safe place for all.
“We are proud to have a multi-faith chaplaincy and four broad staff networks that are dedicated to promoting diversity, inclusion and respect within the Trust.
“It is incorrect to allege that any one community was responsible for the decision to not use Campaign Against Antisemitism to deliver training. After reviewing CAA’s content, the Trust decided they were not the right organisation for this work.
“We are in discussions with other providers to deliver this important antisemitism awareness training and will consult with our staff throughout.”
Thousands join world-first trial to save lives of critically ill children
Some of the sickest children in the UK have started to join an innovative clinical trial designed to improve the survival and recovery of children requiring intensive care treatment, led by GOSH.
Message to our patients and patient families following London-wide power outage
Following a London-wide power outage today, we experienced some local issues at GOSH.
GOSH surgeon receives prestigious international award
Professor Paolo De Coppi, Consultant Paediatric Surgeon at Great Ormond Street Hospital (GOSH), has been recognised as an Honorary Fellow of the American College of Surgeons (ACS), one of the most prestigious honours in global surgery.
Researchers funded to cure inflammatory disease
Researchers from University College London (UCL) and Great Ormond Street Hospital (GOSH) will join researchers across the UK and international partners in a bid to transform how chronic inflammatory disease is treated.